| Investigator |
Title |
Sponsor |
ID |
Dates |
Amount |
| Akanksha Sharma, PHD |
Mechanisms of liver failure |
Department of Veteran Affairs |
VA/IPA_Sharma |
07/02/2019 - 12/31/2019 |
$49,183 |
| Akanksha Sharma, PHD |
Mechanisms of liver failure |
Department of Veteran Affairs |
VA/IPA |
03/17/2020 - 03/16/2021 |
$59,521 |
| Akihiro Asai, MD-PHD |
Modeling patient-specific genetic cholestasis with induced human hepatocytes |
Amer Assoc for the Study of Liver Dis |
AASLD- 2018 AASLD |
07/01/2019 - 10/31/2020 |
$100,000 |
| Alexander Miethke, MD |
Control of hepatic T cell responses in biliary atresia |
National Institutes of Health (NIH) |
R01DK095001 |
07/01/2019 - 04/30/2021 |
$825,726 |
| Alexander Miethke, MD |
A Multicenter Extension Study to Evaluate the Long-Term Safety and Durability of the Therapeutic Effect of LUM001, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi), in the Treatment of Cholestatic Liver Disease in Pediatric Subjects with Alagille Syndrome (“IMAGINE-II”) |
University of Michigan (National Institutes of Health) |
SUBK00012525 |
12/01/2019 - 05/31/2020 |
$79,500 |
| Alok K Verma, PHD |
Mechanisms of liver failure |
Department of Veteran Affairs |
VA,IPA |
03/10/2020 - 03/09/2021 |
$50,377 |
| Chunyue Yin, PHD |
Molecular targets in cholestasis caused by bile salt export pump deficiency |
National Institutes of Health (NIH) |
R01DK117266 |
08/01/2019 - 07/31/2020 |
$362,414 |
| James E Heubi, MD |
Sterol and Isoprenoid Diseases Rare Diseases Consortium |
University of Nebraska Medical Center (National Institutes of Health) |
34-5321-2003-010 |
09/01/2018 - 08/31/2019 |
$8,638 |
| Jorge A Bezerra, MD |
Digestive Health Center: Bench to Bedside Research in Pediatric Digestive Disease |
National Institutes of Health (NIH) |
P30DK078392 |
06/01/2019 - 05/31/2021 |
$2,349,225 |
| Jorge A Bezerra, MD |
Immunologic Dysfunction in Biliary Atresia |
National Institutes of Health (NIH) |
R01DK064008 |
02/01/2020 - 01/31/2021 |
$446,970 |
| Jorge A Bezerra, MD |
Biological Basis of Phenotypes and Clinical Outcomes in Biliary Atresia |
National Institutes of Health (NIH) |
2R01DK083781 |
09/17/2019 - 06/30/2020 |
$526,622 |
| Jorge A Bezerra, MD |
Clinical Center for Cholestatic Liver Disease in Children |
National Institutes of Health (NIH) |
2U01DK062497 |
09/19/2019 - 05/31/2021 |
$1,243,768 |
| Joseph Palermo, MD-PHD |
Longitudinal Study of Cystic Fibrosis Liver Disease |
The Children's Hospital of Denver (Cystic Fibrosis Fdn Therapeutics, Inc) |
NARKEW07AO |
01/01/2019 - 12/31/2019 |
$109,632 |
| Kelli L VanDussen, PHD |
Defining the basis of epithelial defects in Crohn's disease patients |
National Institutes of Health (NIH) |
K01DK109081 |
02/01/2020 - 01/31/2021 |
$144,838 |
| Lee A Denson, MD |
Development of a Human Intestinal Organoid Model for Stricturing Ileal Crohn's Disease |
Crohn's & Colitis Foundation of America |
659172 |
01/01/2020 - 12/31/2020 |
$115,830 |
| Lee A Denson, MD |
Causes and consequences of neutrophil dysfunction in early onset Crohn’s disease |
Emory University (National Institutes of Health) |
A229615 |
03/01/2019 - 02/29/2020 |
$79,500 |
| Lee A Denson, MD |
A multidisciplinary human study on the genetic, environmental and microbial interactions that cause IBD |
Mount Sinai Hospital (Icahn School of Medicine at Mount Sinai) |
Mt. Sinai_GEM_amend |
03/31/2019 - 03/30/2020 |
$1,750 |
| Lee A Denson, MD |
Pediatric Gastroenterology and Nutrition Training Grant |
National Institutes of Health (NIH) |
T32DK007727 |
07/01/2019 - 06/30/2020 |
$478,248 |
| Lee A Denson, MD |
Dosing and Pilot Efficacy of 2'-Fucosyllactose in Inflammatory Bowel Disease |
National Institutes of Health (NIH) |
R01HD094862 |
04/01/2020 - 03/31/2021 |
$666,974 |
| Maisam Abu-El-Haija, MD |
Predicting Severity and Improving the Outcomes of Pediatric Pancreatitis |
National Institutes of Health (NIH) |
K23DK118190 |
06/01/2020 - 05/31/2021 |
$189,292 |
| Maisam Abu-El-Haija, MD |
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC) "Study" |
University of Iowa (National Institutes of Health) |
W001038585 |
09/01/2018 - 08/31/2020 |
$22,000 |
| Maisam Abu-El-Haija, MD |
A randomized trial of a web-based non-pharmacological pain intervention for pediatric chronic pancreatitis |
University of Iowa (National Institutes of Health) |
S00779-01 |
09/15/2018 - 05/31/2020 |
$1,950 |
| Michael Rosen, MD-MS |
The role of SPRY2 in the colonic epithelial response to inflammation |
Children's Hospital Los Angeles (National Institutes of Health) |
RGF011923-A |
08/20/2019 - 05/31/2020 |
$31,592 |
| Michael Rosen, MD-MS |
Type 2 cytokines and innate lymphoid cells in pediatric ulcerative colitis |
National Institutes of Health (NIH) |
R01DK117119 |
06/01/2019 - 05/31/2021 |
$1,033,977 |
| Michael Rosen, MD-MS |
Systems biology of microbe-mediated glucosinolate bioconversion in inflammatory bowel disease |
University of Virginia (National Institute for Health Research) |
R01AT010253 |
09/01/2018 - 08/31/2020 |
$80,181 |
| Phillip P. Minar, MD |
Pharmacokinetic Evaluation to Optimize Infliximab Monotherapy with Personalized Pharmacodynamic Biomarkers |
National Institutes of Health (NIH) |
R03DK118314 |
09/01/2019 - 08/31/2020 |
$119,250 |
| Stacey Huppert, PHD |
Building a functional biliary system from hepatocytes |
National Institutes of Health (NIH) |
R01 DK107553 |
08/01/2019 - 07/31/2020 |
$434,900 |
| Stacey Huppert, PHD |
Molecular regulation of hepatic cell differentiation and maturation |
National Institutes of Health (NIH) |
R01DK120765 |
09/23/2019 - 07/31/2020 |
$402,806 |
| Stavra A Xanthakos, MD |
Non Alcoholic Steatohepatitis Clinical Research Network |
Cleveland Clin Lerner Col of Med of CWRU (National Institutes of Health) |
1324-SUB |
07/01/2019 - 06/30/2020 |
$162,070 |
| Takanori Takebe, MD |
Novel Human Liver Organoid Transplantation Against Pediatric Liver Disease |
Dr. Ralph & Marian Falk Med Res Trust Aw |
FMR_Takebe |
11/30/2019 - 11/29/2020 |
$300,000 |
| Takanori Takebe, MD |
Clinical Translation Of Organ Bud Transplant Therapy |
The New York Stem Cell Foundation |
NYSCF-R-I38 |
01/01/2019 - 12/31/2019 |
$300,000 |
| Xiaonan Han, PHD |
Regulation of Niche Cell Differentiation to Sustain Intestinal Stem Cell Regeneration Against Gut Inflammation |
National Institutes of Health (NIH) |
R01DK123299 |
01/01/2020 - 12/31/2020 |
$357,750 |
| Current Year Direct |
$11,134,484 |
